MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET 2022-2028

 

 

TABLE OF CONTENTS   

1.     MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE MEDICAL ENZYMES MARKET

2.2. KEY INSIGHTS

2.2.1.    ADVANCEMENTS IN ENZYME ENGINEERING

2.2.2.    INCREASED DEMAND IN THE PHARMACEUTICAL SECTOR

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. KEY IMPACT ANALYSIS

2.4.1.    PRICE

2.4.2.    QUALITY

2.4.3.    USAGE

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.7.1.    RESEARCH AND DEVELOPMENT

2.7.2.    OPERATIONS

2.7.3.    OUTBOUND LOGISTICS

2.8. KEY MARKET STRATEGIES

2.8.1.    MERGERS & ACQUISITIONS

2.8.2.    PRODUCT LAUNCHES & DEVELOPMENTS

2.8.3.    PARTNERSHIPS & AGREEMENTS

2.8.4.    BUSINESS EXPANSIONS & DIVESTITURES

2.9. MARKET DRIVERS

2.9.1.    RISING INVESTMENTS IN RESEARCH AND DEVELOPMENT

2.9.2.    RISING AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES

2.9.3.    INCREASING APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY

2.10.               MARKET CHALLENGES

2.10.1.                    STRICT REGULATIONS

2.10.2.                    SAFETY CONCERNS WHILE HANDLING ENZYMES

2.11.               MARKET OPPORTUNITIES

2.11.1.                    RISING HEALTH ISSUES AND GROWING AWARENESS

2.11.2.                    RISING DEMAND FOR SPECIALTY ENZYMES

3.     MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE

3.1. HYDROLASE

3.1.1.    HYALURONIDASE

3.1.2.    LYSOZYMES

3.1.3.    OTHER HYDROLASES ENZYMES

3.2. THROMBOLYTIC ENZYME

3.2.1.    STREPTOKINASE

3.2.2.    UROKINASE

3.2.3.    OTHER THROMBOLYTIC ENZYMES

3.3. DIGESTIVE ENZYME

3.3.1.    LACTASE

3.3.2.    L-ASPARAGINASE

3.3.3.    OTHER DIGESTIVE ENZYMES

3.4. ENDONUCLEASE

3.4.1.    BENZONASE

3.4.2.    OTHER ENDONUCLEASES

4.     MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION

4.1. DISEASE TREATMENT

4.2. DIAGNOSTIC TOOLS

4.3. BIOMEDICAL RESEARCH

4.4. OTHER APPLICATIONS

5.     MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK

5.1. UNITED ARAB EMIRATES

5.2. SAUDI ARABIA

5.3. TURKEY

5.4. SOUTH AFRICA

5.5. REST OF MIDDLE EAST & AFRICA

6.     COMPETITIVE LANDSCAPE

6.1. BASF SE

6.2. DUPONT

6.3. ROCHE HOLDING AG

6.4. NOVOZYMES

6.5. DSM

6.6. SANOFI SA

6.7. CODEXIS

6.8. ADVANCED ENZYMES

6.9. AMANO ENZYME

6.10.               BBI SOLUTIONS

6.11.               THERMOFISHER SCIENTIFIC INC

6.12.               CPC BIOTECH

6.13.               NOVUS

6.14.               BRAIN BIOTECH AG

6.15.               SEKISUI

7.     RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.2. SOURCES OF DATA

7.3. RESEARCH METHODOLOGY

 

 LIST OF TABLES

TABLE 1: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: APPLICATIONS OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF MERGERS & ACQUISITIONS

TABLE 5: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 6: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 7: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

TABLE 8: MEDICAL APPLICATION OF VARIOUS ENZYMES

TABLE 9: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 10: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 11: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

TABLE 12: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

TABLE 13: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

TABLE 14: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 15: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

 

LIST OF FIGURES

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 5: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)

FIGURE 6: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)

FIGURE 7: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)

FIGURE 8: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)

FIGURE 9: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 10: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 11: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN %)

FIGURE 12: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)

FIGURE 13: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)

FIGURE 14: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 15: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)

FIGURE 17: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)

FIGURE 18: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)

FIGURE 19: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $ MILLION)

FIGURE 20: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)

FIGURE 21: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE ENZYME, 2021 & 2028 (IN %)

FIGURE 22: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)

FIGURE 23: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $ MILLION)

FIGURE 24: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 25: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $ MILLION)

FIGURE 26: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $ MILLION)

FIGURE 27: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $ MILLION)

FIGURE 28: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 29: MIDDLE EAST AND AFRICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 30: UNITED ARAB EMIRATES MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 31: SAUDI ARABIA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 32: TURKEY MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 33: SOUTH AFRICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

FIGURE 34: REST OF MIDDLE EAST & AFRICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)

 

Increasing government initiatives to boost the medical enzymes market’s growth

 

Get more insights into the Middle East and Africa Medical Enzymes Market:

 

https://www.tritonmarketresearch.com/reports/middle-east-and-africa-medical-enzymes-market

 

 

MARKET OUTLOOK

Triton Market Research’s report infers that the Middle East and Africa medical enzymes market is estimated to advance at a compound annual growth rate of 7.16% during the forecast years 2022-2028. South Africa, the UAE, Saudi Arabia, Turkey, and Rest of Middle East & Africa are considered in the given region.

Over the years, healthcare spending in Turkey has soared significantly. The government has launched a universal healthcare scheme to offer quality healthcare services. This is mainly owing to the rising geriatric population base. Additionally, the surge in non-communicable diseases has increased the demand for medical enzymes. The increase in government initiatives and the high prevalence of chronic conditions have also surged medical enzyme demand. Thus, these factors drive the studied market’s growth.

Similarly, the South African government has launched various programs to increase access to medications. For instance, the government launched the National Health Insurance initiatives to provide better healthcare services. Moreover, incentives to promote local manufacturing of pharma products have enhanced the demand for medical enzymes. Thus, as stated above, favorable government initiatives are expected to create growth opportunities for the medical enzymes market. 

 

COMPETITIVE OUTLOOK

The notable companies in the medical enzymes market include BASF SE, Novozymes, DSM, Roche Holding AG, Advanced Enzymes, and CPC Biotech.

 

SEGMENTATION

1.     BASF SE

2.     DUPONT

3.     ROCHE HOLDING AG

4.     NOVOZYMES

5.     DSM

6.     SANOFI SA

7.     CODEXIS

8.     ADVANCED ENZYMES

9.     AMANO ENZYME

10. BBI SOLUTIONS

11. THERMOFISHER SCIENTIFIC INC

12. CPC BIOTECH

13. NOVUS

14. BRAIN BIOTECH AG

15. SEKISUI